| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| Domain | Cortactin-binding_p2_N | 5.88e-06 | 4 | 19 | 2 | IPR019131 | |
| Domain | CortBP2 | 5.88e-06 | 4 | 19 | 2 | PF09727 | |
| Domain | Sushi | 1.26e-03 | 52 | 19 | 2 | PF00084 | |
| Domain | CCP | 1.36e-03 | 54 | 19 | 2 | SM00032 | |
| Domain | SUSHI | 1.46e-03 | 56 | 19 | 2 | PS50923 | |
| Domain | Sushi_SCR_CCP_dom | 1.51e-03 | 57 | 19 | 2 | IPR000436 | |
| Domain | - | 5.12e-03 | 106 | 19 | 2 | 1.10.150.50 | |
| Domain | SAM/pointed | 6.21e-03 | 117 | 19 | 2 | IPR013761 | |
| Pathway | WP_REGULATORY_CIRCUITS_OF_STAT3_SIGNALING | 8.66e-05 | 78 | 16 | 3 | M39824 | |
| Pathway | REACTOME_TRANSCRIPTIONAL_REGULATION_BY_RUNX1 | 1.21e-04 | 237 | 16 | 4 | M27786 | |
| Pubmed | 9.42e-07 | 3 | 20 | 2 | 16491350 | ||
| Pubmed | 1.88e-06 | 4 | 20 | 2 | 10815800 | ||
| Pubmed | 9.43e-06 | 1429 | 20 | 7 | 35140242 | ||
| Pubmed | 2.44e-05 | 13 | 20 | 2 | 25802403 | ||
| Pubmed | 2.85e-05 | 14 | 20 | 2 | 17152005 | ||
| Pubmed | Proximity labeling reveals dynamic changes in the SQSTM1 protein network. | 3.11e-05 | 322 | 20 | 4 | 39098523 | |
| Pubmed | Differential Etv2 threshold requirement for endothelial and erythropoietic development. | 7.21e-05 | 22 | 20 | 2 | 35649376 | |
| Pubmed | Characterization of definitive lymphohematopoietic stem cells in the day 9 murine yolk sac. | 7.21e-05 | 22 | 20 | 2 | 9324354 | |
| Pubmed | 1.45e-04 | 31 | 20 | 2 | 20398657 | ||
| Pubmed | 2.81e-04 | 225 | 20 | 3 | 12168954 | ||
| Pubmed | 2.93e-04 | 44 | 20 | 2 | 23817569 | ||
| Pubmed | 4.43e-04 | 263 | 20 | 3 | 34702444 | ||
| Cytoband | Ensembl 112 genes in cytogenetic band chr11q24 | 3.11e-03 | 191 | 20 | 2 | chr11q24 | |
| GeneFamily | Ataxins|Trinucleotide repeat containing | 1.65e-04 | 25 | 14 | 2 | 775 | |
| GeneFamily | CD molecules|I-set domain containing|Immunoglobulin like domain containing|Interleukin receptors|TIR domain containing | 4.71e-04 | 42 | 14 | 2 | 602 | |
| GeneFamily | Hyalectan proteoglycans|V-set domain containing|Sushi domain containing|C-type lectin domain containing | 8.67e-04 | 57 | 14 | 2 | 1179 | |
| Coexpression | GSE37301_HEMATOPOIETIC_STEM_CELL_VS_RAG2_KO_NK_CELL_DN | 1.02e-05 | 183 | 20 | 4 | M8886 | |
| Coexpression | TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_SUSTAINED_IN_GRANULOCYTE_DN | 1.16e-05 | 7 | 20 | 2 | M6161 | |
| Coexpression | TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_HSC_DN | 1.26e-05 | 193 | 20 | 4 | M4723 | |
| Coexpression | TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_GRANULOCYTE_DN | 8.40e-05 | 18 | 20 | 2 | M17148 | |
| Coexpression | GAVIN_IL2_RESPONSIVE_FOXP3_TARGETS_UP | 9.39e-05 | 19 | 20 | 2 | M1739 | |
| Coexpression | GAVIN_IL2_RESPONSIVE_FOXP3_TARGETS_UP | 9.39e-05 | 19 | 20 | 2 | MM1219 | |
| Coexpression | GSE40274_CTRL_VS_IRF4_TRANSDUCED_ACTIVATED_CD4_TCELL_UP | 2.45e-04 | 162 | 20 | 3 | M9085 | |
| Coexpression | CARRILLOREIXACH_MRS3_VS_LOWER_RISK_HEPATOBLASTOMA_DN | 2.72e-04 | 168 | 20 | 3 | M45039 | |
| Coexpression | GSE37301_PRO_BCELL_VS_RAG2_KO_NK_CELL_DN | 3.28e-04 | 179 | 20 | 3 | M8900 | |
| Coexpression | GSE45365_WT_VS_IFNAR_KO_CD8A_DC_MCMV_INFECTION_DN | 4.09e-04 | 193 | 20 | 3 | M9966 | |
| Coexpression | GSE15659_NAIVE_VS_PTPRC_NEG_CD4_TCELL_UP | 4.09e-04 | 193 | 20 | 3 | M3536 | |
| Coexpression | GSE16522_ANTI_CD3CD28_STIM_VS_UNSTIM_NAIVE_CD8_TCELL_DN | 4.40e-04 | 198 | 20 | 3 | M3667 | |
| Coexpression | GSE19941_LPS_VS_LPS_AND_IL10_STIM_IL10_KO_NFKBP50_KO_MACROPHAGE_DN | 4.47e-04 | 199 | 20 | 3 | M8100 | |
| Coexpression | GSE9509_LPS_VS_LPS_AND_IL10_STIM_IL10_KO_MACROPHAGE_10MIN_UP | 4.47e-04 | 199 | 20 | 3 | M6895 | |
| Coexpression | GSE32986_UNSTIM_VS_GMCSF_STIM_DC_UP | 4.47e-04 | 199 | 20 | 3 | M8609 | |
| Coexpression | GSE24972_MARGINAL_ZONE_BCELL_VS_FOLLICULAR_BCELL_IRF8_KO_DN | 4.47e-04 | 199 | 20 | 3 | M8093 | |
| Coexpression | GSE40666_UNTREATED_VS_IFNA_STIM_STAT4_KO_EFFECTOR_CD8_TCELL_90MIN_DN | 4.47e-04 | 199 | 20 | 3 | M9236 | |
| Coexpression | HALLMARK_IL2_STAT5_SIGNALING | 4.47e-04 | 199 | 20 | 3 | M5947 | |
| Coexpression | GSE16450_CTRL_VS_IFNA_6H_STIM_MATURE_NEURON_CELL_LINE_UP | 4.47e-04 | 199 | 20 | 3 | M7420 | |
| Coexpression | GSE3039_CD4_TCELL_VS_NKT_CELL_DN | 4.53e-04 | 200 | 20 | 3 | M6431 | |
| Coexpression | GSE14769_UNSTIM_VS_360MIN_LPS_BMDM_DN | 4.53e-04 | 200 | 20 | 3 | M3510 | |
| Coexpression | GSE21546_ELK1_KO_VS_SAP1A_KO_AND_ELK1_KO_ANTI_CD3_STIM_DP_THYMOCYTES_DN | 4.53e-04 | 200 | 20 | 3 | M7531 | |
| Coexpression | GSE360_DC_VS_MAC_B_MALAYI_HIGH_DOSE_UP | 4.53e-04 | 200 | 20 | 3 | M5185 | |
| Coexpression | GSE7460_TCONV_VS_TREG_LN_DN | 4.53e-04 | 200 | 20 | 3 | M5674 | |
| Coexpression | GSE14350_IL2RB_KO_VS_WT_TEFF_DN | 4.53e-04 | 200 | 20 | 3 | M3424 | |
| Coexpression | GSE14350_TREG_VS_TEFF_IN_IL2RB_KO_UP | 4.53e-04 | 200 | 20 | 3 | M3419 | |
| ToppCell | ASK452-Immune-Mast_cell|ASK452 / Donor, Lineage and Cell class of Lung cells from Dropseq | 1.78e-08 | 188 | 20 | 5 | 840215e16cff90f821f776186284eafcf2350690 | |
| ToppCell | 3'_v3-GI_small-bowel-Mast-Mast_cells|GI_small-bowel / Manually curated celltypes from each tissue | 2.31e-08 | 198 | 20 | 5 | 920d2e6603a06c2e8dcb6be127202d222c662bca | |
| ToppCell | 3'_v3-GI_small-bowel-Mast|GI_small-bowel / Manually curated celltypes from each tissue | 2.31e-08 | 198 | 20 | 5 | 807e3ed34739eca159dd0970f884b073e588c649 | |
| ToppCell | critical-Myeloid-Mast_cell|critical / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 8.07e-07 | 165 | 20 | 4 | 34a1cc6ccd46c059354e8fbde1ac69f202695a4e | |
| ToppCell | NS-critical-d_07-13-Myeloid-Mast_cell|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 8.47e-07 | 167 | 20 | 4 | 8a14fd980d8ebe8ef0216221f619d31aaa27ff15 | |
| ToppCell | Control-Myeloid-Mast|World / Disease state, Lineage and Cell class | 9.31e-07 | 171 | 20 | 4 | ed8e61d524f4cddc6084b261175df54d2a64a60f | |
| ToppCell | moderate-Myeloid-Mast_cell|moderate / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 1.02e-06 | 175 | 20 | 4 | bbd2971bc6d69e507f90a637834d0936c205c590 | |
| ToppCell | COVID-19-Myeloid-MoAM4|COVID-19 / Condition, Lineage and Cell class | 1.07e-06 | 177 | 20 | 4 | ca5d0c3d5c700bbe4c2da068eb02be6229afb9a0 | |
| ToppCell | severe-Myeloid-Eosinophils|Myeloid / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 1.14e-06 | 180 | 20 | 4 | ac03812b1409435c55d323a7516deeac82bd3509 | |
| ToppCell | normal_Lung-Myeloid_cells-CD207+CD1a+_LCs|normal_Lung / Location, Cell class and cell subclass | 1.17e-06 | 181 | 20 | 4 | b55dbcfae8c92d322071906831489830a22239b9 | |
| ToppCell | normal_Lung-Myeloid_cells-CD207+CD1a+_LCs|Myeloid_cells / Location, Cell class and cell subclass | 1.19e-06 | 182 | 20 | 4 | 8dd79fef8f8463ad3194f9cc07c6cacf2c886304 | |
| ToppCell | IPF-Myeloid-Mast|IPF / Disease state, Lineage and Cell class | 1.25e-06 | 184 | 20 | 4 | c3baf21f10b45cf91ac99997a59f353bcf3de8b7 | |
| ToppCell | BAL-Severe-Myeloid-cDC-cDC-cDC_0|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.36e-06 | 188 | 20 | 4 | 9fc3819aae5a2b2534cb131d467435b5cfc420d6 | |
| ToppCell | BAL-Severe-Myeloid-cDC-cDC-cDC_0|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.36e-06 | 188 | 20 | 4 | 5e5d779ea079d3b2a1ef650b06b9f5cc1ffef5e7 | |
| ToppCell | ASK452-Immune-Mast_cell|Immune / Donor, Lineage and Cell class of Lung cells from Dropseq | 1.48e-06 | 192 | 20 | 4 | 8269b88ff6073a908f547fcc7c5941f2e8289694 | |
| ToppCell | (7)_Mast_cell|World / shred on Cell_type and subtype | 1.70e-06 | 199 | 20 | 4 | c0b5f1cb435da99a7e2ebac9ee7d7b1bd0e49b42 | |
| ToppCell | Sigmoid-Mast_cell|Sigmoid / Region, Cell class and subclass | 1.74e-06 | 200 | 20 | 4 | 025125d8b9c6540d9cdeea7f0fe9c58aec2a16b0 | |
| ToppCell | Sigmoid-(7)_Mast_cell|Sigmoid / shred on region, Cell_type, and subtype | 1.74e-06 | 200 | 20 | 4 | bd8e0f027055bb34e99aa0e271ec3a0912f666bb | |
| ToppCell | Caecum-(7)_Mast_cell|Caecum / shred on region, Cell_type, and subtype | 1.74e-06 | 200 | 20 | 4 | d23fe8644ce42ace51fcde43cb4cd22a99300c02 | |
| ToppCell | Caecum-Mast_cell|Caecum / Region, Cell class and subclass | 1.74e-06 | 200 | 20 | 4 | 8791d0b3d883e7a747a23d21118817f5be4013b6 | |
| ToppCell | Caecum-(7)_Mast_cell-(70)_Mast|Caecum / shred on region, Cell_type, and subtype | 1.74e-06 | 200 | 20 | 4 | 9974285c28a633a010c4f24d035ad3685705e881 | |
| ToppCell | Transverse-(7)_Mast_cell-(70)_Mast|Transverse / shred on region, Cell_type, and subtype | 1.74e-06 | 200 | 20 | 4 | aa17354c83b0967707d995e4b74e042ac211f814 | |
| ToppCell | Sigmoid-Mast_cell-Mast|Sigmoid / Region, Cell class and subclass | 1.74e-06 | 200 | 20 | 4 | e7e49e192a86566ed96f1e54657dd2ebc9036d47 | |
| ToppCell | Sigmoid-(7)_Mast_cell-(70)_Mast|Sigmoid / shred on region, Cell_type, and subtype | 1.74e-06 | 200 | 20 | 4 | 7224ee639d56509de854203653a85ab09e6f05fe | |
| ToppCell | Transverse-Mast_cell-Mast|Transverse / Region, Cell class and subclass | 1.74e-06 | 200 | 20 | 4 | 0af942a33cc50da65129204976e24203320e206d | |
| ToppCell | Caecum-Mast_cell-Mast|Caecum / Region, Cell class and subclass | 1.74e-06 | 200 | 20 | 4 | 168426e8296697d05684d71989c4eb5bb2a0489f | |
| ToppCell | Transverse-Mast_cell|Transverse / Region, Cell class and subclass | 1.74e-06 | 200 | 20 | 4 | 5e3f5349ffbcabdca3d911fbc99a46aaa56c47c4 | |
| ToppCell | Transverse-(7)_Mast_cell|Transverse / shred on region, Cell_type, and subtype | 1.74e-06 | 200 | 20 | 4 | d90d1d3015a9258298bd6b4ba07971aa1af8b82b | |
| ToppCell | (70)_Mast|World / shred on Cell_type and subtype | 1.84e-06 | 203 | 20 | 4 | b7af2130b4965661b5a50717a7f82d8d498f8d08 | |
| ToppCell | Severe-Myeloid-Mast-|Severe / Condition, Lineage, Cell class and cell subclass | 3.59e-05 | 145 | 20 | 3 | ce307d45425a5191882078f049f85477eec40b69 | |
| ToppCell | Severe-Myeloid-Mast|Severe / Condition, Lineage, Cell class and cell subclass | 3.59e-05 | 145 | 20 | 3 | e0bfd2ffdbd6c197ef0a04e983396ebd87ef7127 | |
| ToppCell | primary_visual_cortex-Non-neuronal-pericyte_cell-Peri|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 4.38e-05 | 155 | 20 | 3 | d8b5145258f075b15080f8739f537f48dd22225e | |
| ToppCell | primary_visual_cortex-Non-neuronal-pericyte_cell-Peri-Peri_Kcnj8|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 4.38e-05 | 155 | 20 | 3 | ced64e26962c5c6e6d539f361fe57ab0b399e999 | |
| ToppCell | primary_visual_cortex-Non-neuronal-pericyte_cell|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 4.38e-05 | 155 | 20 | 3 | 0f24ef6486aef354f0911c06932cb01d1a0525ac | |
| ToppCell | NS-critical-d_16-33-Myeloid-Mast_cell|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 4.81e-05 | 160 | 20 | 3 | c61869d9dbba250270e59366e15af204e5b4395d | |
| ToppCell | NS-moderate-d_16-33-Myeloid-Mast_cell|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 5.18e-05 | 164 | 20 | 3 | 35c673380f75cb4bfe080089bc723c4373bcc7a5 | |
| ToppCell | Mild-Myeloid-Mast-|Mild / Condition, Lineage, Cell class and cell subclass | 5.27e-05 | 165 | 20 | 3 | 93d3909a0f5f43d473d5005c842d7d73e25eceed | |
| ToppCell | 10x5'-bone_marrow-Lymphocytic_T_CD4-Tregs|bone_marrow / Manually curated celltypes from each tissue | 5.27e-05 | 165 | 20 | 3 | 1ae1ad4e1fe19b6eefff0f9a03d58a384f169759 | |
| ToppCell | Mild-Myeloid-Mast|Mild / Condition, Lineage, Cell class and cell subclass | 5.27e-05 | 165 | 20 | 3 | 5fa9552c37890c5cc7e672a47038aebba2413cb4 | |
| ToppCell | moderate-Myeloid-Mast_cell|Myeloid / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 5.37e-05 | 166 | 20 | 3 | c3835b424c63bf11a4e2c47635dc3787fc4a637a | |
| ToppCell | mild-Lymphocytic-CD4_T_cells_3|Lymphocytic / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 5.37e-05 | 166 | 20 | 3 | f8f8423423d72f0ea0266b59126abb27beb23094 | |
| ToppCell | LAM-Myeloid-Mast|LAM / Condition, Lineage and Cell class | 5.37e-05 | 166 | 20 | 3 | e0ce973cc2a091b832c67b3b32dc153379daa2ef | |
| ToppCell | COVID-19_Severe-CD4+_T_activated|COVID-19_Severe / Disease condition and Cell class | 5.37e-05 | 166 | 20 | 3 | 0f138dbafad6f83975944e8f6398411127b150cc | |
| ToppCell | COVID-19_Moderate-Treg|COVID-19_Moderate / disease group, cell group and cell class | 5.47e-05 | 167 | 20 | 3 | 4ddb21421cbe72c06b61dd3a5eb1337e59de42e5 | |
| ToppCell | Sigmoid-Macrophage-Macrophage|Macrophage / Region, Cell class and subclass | 5.56e-05 | 168 | 20 | 3 | bb16e135b6ae0d66615420b61edd6f62f2a3233c | |
| ToppCell | ASK428-Immune-Mast_cell|Immune / Donor, Lineage and Cell class of Lung cells from Dropseq | 5.56e-05 | 168 | 20 | 3 | c399fcb4d1d0be48026c2ecabc34a5935e7adf73 | |
| ToppCell | IIF-Lymphocyte-T_NK-Treg|IIF / Disease, Lineage and Cell Type | 5.66e-05 | 169 | 20 | 3 | aac6ff89e0b3bc1f644e6cc6a696360659b254b5 | |
| ToppCell | COVID-19_Moderate-Treg|World / disease group, cell group and cell class | 5.66e-05 | 169 | 20 | 3 | 27ad11239559b025bef582f89b2a83501d9d3993 | |
| ToppCell | Control-T_cells-Tregs|Control / group, cell type (main and fine annotations) | 5.66e-05 | 169 | 20 | 3 | e1e0983f31ec81b3fad5f9c6140d17f03f81a5dc | |
| ToppCell | COVID-19-lung-MAST|lung / Disease (COVID-19 only), tissue and cell type | 5.76e-05 | 170 | 20 | 3 | e90f18e5462381b38e918442b38b1c8105291908 | |
| ToppCell | Control-Myeloid-Mast|Control / Disease state, Lineage and Cell class | 5.76e-05 | 170 | 20 | 3 | 9a14deb7f7cd4a49c217eba4023f7bf1dec6c902 | |
| ToppCell | COVID-19_Severe-Treg|COVID-19_Severe / disease group, cell group and cell class | 5.76e-05 | 170 | 20 | 3 | d61269a51283125835884c4aa50623756c4fdda2 | |
| ToppCell | severe-Myeloid-Eosinophils|severe / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 5.76e-05 | 170 | 20 | 3 | 863f0266d5837cdbc3e09a3fe6a99dd3e6261674 | |
| ToppCell | mild-Myeloid-Eosinophils|Myeloid / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 5.86e-05 | 171 | 20 | 3 | 5c8198182495bda7a826e9d80aa467f4eb1094ec | |
| ToppCell | droplet-Liver-Hepatocytes-21m-Myeloid-Kupffer_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.97e-05 | 172 | 20 | 3 | 574ebdf36e45222bcd907cd2c2ee7ff50ed4573a | |
| ToppCell | droplet-Liver-nan-3m-Myeloid-Kupffer_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.97e-05 | 172 | 20 | 3 | 1f335ccb92b22d0412954e8fc3af212f96410b67 | |
| ToppCell | PND01-Immune-Immune_Myeloid-Granulocytic-Basophil|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.97e-05 | 172 | 20 | 3 | 6503e85182eb6e8a40a890e393e9ac5c5350e322 | |
| ToppCell | droplet-Liver-nan-3m-Myeloid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.97e-05 | 172 | 20 | 3 | bb96c896d125e10b71e94e2bdad243899045af5c | |
| ToppCell | droplet-Liver-Hepatocytes-21m-Myeloid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.97e-05 | 172 | 20 | 3 | 1627fa7035b0e0bbc82a1c0f000d8231254c680a | |
| ToppCell | PND01-Immune-Immune_Myeloid-Granulocytic-Basophil-Basophil_mature|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.97e-05 | 172 | 20 | 3 | 3c0bf7200e582ee730af49dcd86446e112226aca | |
| ToppCell | 5'-Adult-Appendix-Hematopoietic-Myeloid-Mast_cell|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.07e-05 | 173 | 20 | 3 | a7dee23b1d43d3070d502487af319ff81a9a747b | |
| ToppCell | droplet-Kidney-nan-3m-Lymphocytic-B_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.17e-05 | 174 | 20 | 3 | ce9bdd02dc8eb45ba9c1481619c0089b465e6442 | |
| ToppCell | Healthy_Control-Myeloid-Mast-|Healthy_Control / Condition, Lineage, Cell class and cell subclass | 6.28e-05 | 175 | 20 | 3 | eadbbcdf2aef4cee268bc70a7a2c4175d898953b | |
| ToppCell | Healthy_Control-Myeloid-Mast|Healthy_Control / Condition, Lineage, Cell class and cell subclass | 6.28e-05 | 175 | 20 | 3 | ca187074adcc9b8bd0fa270e2ede1564c8e6c6cf | |
| ToppCell | 3'-GW_trimst-2-SmallIntestine-Hematopoietic-T_cells-Treg|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.39e-05 | 176 | 20 | 3 | 88247142c6482f3b4fa845d64e6189c690a5ee52 | |
| ToppCell | Control-Myeloid-Mast|Myeloid / Disease state, Lineage and Cell class | 6.39e-05 | 176 | 20 | 3 | 0c5916d63e1ada09105e46d2429b75129b7329ec | |
| ToppCell | 5'-Adult-SmallIntestine-Hematopoietic-Myeloid-Mast_cell|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.50e-05 | 177 | 20 | 3 | 0176ffa5e66fa684d0a8264af0db8f77fc391afd | |
| ToppCell | 10x5'-GI_large-bowel-Mast-Mast_cells|GI_large-bowel / Manually curated celltypes from each tissue | 6.61e-05 | 178 | 20 | 3 | 8fc5f735afa25ae43c2acb1c710ade6e9e093e3c | |
| ToppCell | ASK440-Immune-Mast_cell|ASK440 / Donor, Lineage and Cell class of Lung cells from Dropseq | 6.61e-05 | 178 | 20 | 3 | dcefc4afca3a40d1bd44722e66bca6b45a6c6c55 | |
| ToppCell | 10x5'-GI_large-bowel-Mast|GI_large-bowel / Manually curated celltypes from each tissue | 6.61e-05 | 178 | 20 | 3 | d10ed2543c96e1a2373f847e0b82144771e26d07 | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-CD4+_T-Treg-Treg_2|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 6.72e-05 | 179 | 20 | 3 | 593fc323b28304a57ae162f64b0890b893fff446 | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-CD4+_T-Treg-Treg_2|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 6.72e-05 | 179 | 20 | 3 | 708fc0b8ffcb5fac43c52541acb6671fe1cfbb0d | |
| ToppCell | 5'-Adult-LargeIntestine-Hematopoietic-Myeloid-Mast_cell|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.83e-05 | 180 | 20 | 3 | 2658a6be43d6d94767b4fc5af2d8632469a8a979 | |
| ToppCell | critical-Myeloid-Mast_cell|Myeloid / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 6.94e-05 | 181 | 20 | 3 | f0d81ae74d3f32979624a94b2ef93774831a7970 | |
| ToppCell | COPD-Myeloid-Mast|World / Disease state, Lineage and Cell class | 7.06e-05 | 182 | 20 | 3 | 68a1e7b804f309bfd6c23d65fad20a9a962712ae | |
| ToppCell | COVID-19-kidney-CD-IC-A|kidney / Disease (COVID-19 only), tissue and cell type | 7.17e-05 | 183 | 20 | 3 | 5c7597a5b2bf6a481ca2c7e68560179214150fa0 | |
| ToppCell | 10x_3'_v3-lymph_node_(10x_3'_v3)-myeloid-myeloid_granulocytic-mast_cell|lymph_node_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 7.17e-05 | 183 | 20 | 3 | 5ac38a2ce93c53f23a89faf287b81ea138560623 | |
| ToppCell | mild-Lymphocytic-CD4_T_cells_3|mild / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 7.17e-05 | 183 | 20 | 3 | 61688846d398fbf086ea66a7b88cdf632f9d8c25 | |
| ToppCell | 3'_v3-lymph-node_spleen-Mast-Mast_cells|lymph-node_spleen / Manually curated celltypes from each tissue | 7.29e-05 | 184 | 20 | 3 | ed266bd2d12f86e8786473e64fbcd58319cd4c2a | |
| ToppCell | 3'_v3-lymph-node_spleen-Mast|lymph-node_spleen / Manually curated celltypes from each tissue | 7.29e-05 | 184 | 20 | 3 | 83675c7a083c52fb74dc8b9d35df0ef69715f707 | |
| ToppCell | PBMC-Control-Lymphocyte-T/NK-CD4+_T-Treg-Treg_0|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 7.29e-05 | 184 | 20 | 3 | 300edc4aa3ce55f309005c02c315fa0102ea9da7 | |
| ToppCell | IPF-Myeloid-Mast|Myeloid / Disease state, Lineage and Cell class | 7.29e-05 | 184 | 20 | 3 | 7326a16d7d3ae41b8c9d2beaec7f977b374f3469 | |
| ToppCell | PBMC-Control-Lymphocyte-T/NK-CD4+_T-Treg-Treg_0|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 7.29e-05 | 184 | 20 | 3 | 8b397f9c18ed7abecdbcbd586d0ddadf07cf6e75 | |
| ToppCell | control-Myeloid-Eosinophils|Myeloid / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 7.29e-05 | 184 | 20 | 3 | fad517d047e8eaeaa5bd4f311d770880568dd13c | |
| ToppCell | 10x5'-blood-Lymphocytic_T_CD4-Tregs|blood / Manually curated celltypes from each tissue | 7.29e-05 | 184 | 20 | 3 | 22c15ce30171c687ab564f4383ae74d38b759272 | |
| ToppCell | IPF-Myeloid-Mast|World / Disease state, Lineage and Cell class | 7.29e-05 | 184 | 20 | 3 | 7aefa182acad5a53c730945fec85329d7168606a | |
| ToppCell | LPS_only-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_2|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.29e-05 | 184 | 20 | 3 | 327ff3ac8d2fecdd5d242bdc34f0dfdb1c59a68b | |
| ToppCell | Smart-seq2-tissue-resident_(Smart-seq2)-myeloid-myeloid_granulocytic-mast_cell|tissue-resident_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 7.41e-05 | 185 | 20 | 3 | 3fafb1d36c5f98a29d20a5ce5192c83d6f603514 | |
| ToppCell | Smart-seq2-tissue-resident_(Smart-seq2)-myeloid-myeloid_granulocytic|tissue-resident_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 7.53e-05 | 186 | 20 | 3 | de55471dd5c842026b409cfebf67fe32f079a011 | |
| ToppCell | COPD-Myeloid-Mast|COPD / Disease state, Lineage and Cell class | 7.53e-05 | 186 | 20 | 3 | def6f0f284acc2154738574c8c5d3d2a5ef1f208 | |
| ToppCell | 10x_5'_v1-Non-neoplastic-Myeloid-Mono-Mono_anti-infl|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 7.53e-05 | 186 | 20 | 3 | 8694ca16c9780729f4fba67ba20e35745f1eb4e9 | |
| ToppCell | 10x_5'_v1-Non-neoplastic-Myeloid-Mono-Mono_anti-infl-Z|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 7.53e-05 | 186 | 20 | 3 | f73cb91e74a806858650ae97f543fc779ba4cff8 | |
| ToppCell | 5'-Parenchyma_lung-Immune_Myeloid_mast-Myeloid_Mast/Baso-mast_cell-Mast_cells|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.65e-05 | 187 | 20 | 3 | bdcef4f3e093c3646b639a189bbe93d6f4c40f3c | |
| ToppCell | 5'-Parenchyma_lung-Immune_Myeloid_mast-Myeloid_Mast/Baso-mast_cell|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.65e-05 | 187 | 20 | 3 | 09348f1e8bbbca8dca885461937b9b1dd248b034 | |
| ToppCell | wk_20-22-Hematologic_Lymphocytic-T_&_ILC-ILC2|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 7.65e-05 | 187 | 20 | 3 | dd5183d2c620b2a87253a9783b70c5df2c36c570 | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-CD4+_T-Treg-Treg_1|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 7.65e-05 | 187 | 20 | 3 | 9fdfca5b70f585843ef9d810154674a8e561e765 | |
| ToppCell | 5'-Parenchyma_lung-Immune_Myeloid_mast|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.65e-05 | 187 | 20 | 3 | 0f7a42c55997e34a0d20e492e16b03e91e965335 | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-CD4+_T-Treg-Treg_1|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 7.65e-05 | 187 | 20 | 3 | a525753a8a908ee1ef0b8f06e68855e4af27bf86 | |
| ToppCell | facs-Spleen-nan-3m-Lymphocytic-CD79a_B_cell|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.65e-05 | 187 | 20 | 3 | b51af2824e65734f333b1325117f4a2e88b17c23 | |
| ToppCell | 5'-Parenchyma_lung-Immune_Myeloid_mast-Myeloid_Mast/Baso|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.65e-05 | 187 | 20 | 3 | 064730fa72f8637c3db3fc34d2e363d2b9a38f1d | |
| Computational | Genes in the cancer module 73. | 3.37e-04 | 23 | 13 | 2 | MODULE_73 | |
| Drug | NKH-1 | 6.99e-06 | 43 | 20 | 3 | CID000061675 | |
| Disease | response to fenofibrate | 4.72e-04 | 50 | 19 | 2 | GO_1901557 | |
| Disease | asthma, response to diisocyanate | 5.97e-04 | 261 | 19 | 3 | EFO_0006995, MONDO_0004979 | |
| Disease | rheumatoid arthritis, ACPA-positive rheumatoid arthritis, rheumatoid factor seropositivity measurement | 7.49e-04 | 63 | 19 | 2 | EFO_0000685, EFO_0007791, EFO_0009459 | |
| Disease | type 1 diabetes mellitus (is_implicated_in) | 1.36e-03 | 85 | 19 | 2 | DOID:9744 (is_implicated_in) | |
| Disease | platelet-to-lymphocyte ratio | 1.55e-03 | 363 | 19 | 3 | EFO_0008446 | |
| Disease | asthma, Eczema, allergic rhinitis | 2.72e-03 | 121 | 19 | 2 | EFO_0005854, HP_0000964, MONDO_0004979 | |
| Disease | rheumatoid arthritis | 3.07e-03 | 462 | 19 | 3 | EFO_0000685 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| NMLNCSQNSSSSSVW | 916 | Q96QP1 | |
| CWSSNNNFLVTASSS | 41 | Q8NHV4 | |
| AANQSQLSNWDTCSS | 341 | P31152 | |
| CDRLTQSWSSQSSFN | 261 | P14921 | |
| IESWNSISNCSQTLS | 66 | Q13651 | |
| VSNTTAQNASSSTWD | 926 | A7KAX9 | |
| SSSSSCQSAATQVQN | 201 | Q8NDX5 | |
| NRTFSESSVWSQQSS | 651 | O15439 | |
| TQCTNCQTTTTTLWR | 256 | P15976 | |
| SSTWGQQSNTTACQS | 926 | Q6Y7W6 | |
| QWTSCSKTCNSGTQS | 31 | P13671 | |
| TQCSQNTKRSSSSSN | 1621 | Q8WZ74 | |
| SWQFQRSNSNSSSVI | 1041 | Q4L180 | |
| SSHSSWDNQCQCTSS | 71 | P01589 | |
| QTSQTSWTSSCTNRN | 106 | Q3SYA9 | |
| SWTSSCTNRNAISSS | 111 | Q3SYA9 | |
| LWNSSQSTSSSSQEN | 66 | Q96E29 | |
| QSETSTQSQSDWSRN | 441 | Q9UGK8 | |
| WNNAASQESTSSCSS | 901 | Q9HCJ0 | |
| NGSLSTTWSQNSRSQ | 16 | Q6IE81 | |
| TDLWQNCSTSSSGNV | 36 | Q01453 |